SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-021966
Filing Date
2023-08-03
Accepted
2023-08-03 16:30:43
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20230630_10q.htm   iXBRL 10-Q 1524631
2 EXHIBIT 31.1 ex_515175.htm EX-31.1 16163
3 EXHIBIT 31.2 ex_515176.htm EX-31.2 16584
4 EXHIBIT 32.1 ex_515177.htm EX-32.1 12871
10 cht02.jpg GRAPHIC 94811
  Complete submission text file 0001437749-23-021966.txt   7016945

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20230630.xsd EX-101.SCH 59891
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20230630_cal.xml EX-101.CAL 45861
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20230630_def.xml EX-101.DEF 398738
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20230630_lab.xml EX-101.LAB 355312
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20230630_pre.xml EX-101.PRE 428970
66 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20230630_10q_htm.xml XML 1079796
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 231140584
SIC: 2836 Biological Products, (No Diagnostic Substances)